Cramer's lightning round: Two thumbs up for AstraZeneca

Cramer's lightning round: Two thumbs up for AstraZenecaПодробнее

Cramer's lightning round: Two thumbs up for AstraZeneca

Cramer's lightning round: I'm sticking by Intuitive SurgicalПодробнее

Cramer's lightning round: I'm sticking by Intuitive Surgical

Cramer's lightning round: I say thumbs up to MP MaterialsПодробнее

Cramer's lightning round: I say thumbs up to MP Materials

Cramer's lightning round: I like ABM IndustriesПодробнее

Cramer's lightning round: I like ABM Industries

Lightning Round: Snap is not investable, says Jim CramerПодробнее

Lightning Round: Snap is not investable, says Jim Cramer

Lightning Round: You don't want to be in Hawaiian Electric, says Jim CramerПодробнее

Lightning Round: You don't want to be in Hawaiian Electric, says Jim Cramer

Cramer's Lightning Round: Novocure, PayPal, AeroVironmentПодробнее

Cramer's Lightning Round: Novocure, PayPal, AeroVironment

Cramer's lightning round: I'm sticking with Bausch HealthПодробнее

Cramer's lightning round: I'm sticking with Bausch Health

Cramer's lightning round: Pass on AstraZenecaПодробнее

Cramer's lightning round: Pass on AstraZeneca

Lightning Round: I was positive on RH while the CEO was negative, says Jim CramerПодробнее

Lightning Round: I was positive on RH while the CEO was negative, says Jim Cramer

Lightning Round: Buy Lam Research slowly, not all at onceПодробнее

Lightning Round: Buy Lam Research slowly, not all at once

Lightning Round: I like PENN because gambling is hot againПодробнее

Lightning Round: I like PENN because gambling is hot again

Lightning Round: I see too much hype and bluff around C3.ai, says Jim CramerПодробнее

Lightning Round: I see too much hype and bluff around C3.ai, says Jim Cramer

Lightning Round: It's a great time to sell Aspin Aerogels, says Jim CramerПодробнее

Lightning Round: It's a great time to sell Aspin Aerogels, says Jim Cramer

Lightning Round: I am too on the fence when it comes to On Running, says Jim CramerПодробнее

Lightning Round: I am too on the fence when it comes to On Running, says Jim Cramer

Cramer's lightning round: SunOpta is a winnerПодробнее

Cramer's lightning round: SunOpta is a winner

Lightning Round: It's not the time to be in fintechПодробнее

Lightning Round: It's not the time to be in fintech

Lightning Round: Stay away from Dexcom, says Jim CramerПодробнее

Lightning Round: Stay away from Dexcom, says Jim Cramer

Jim Cramer's lightning round: I like Broadcomm so muchПодробнее

Jim Cramer's lightning round: I like Broadcomm so much

Cramer's lightning round: Amicus Therapeutics is an ideal specПодробнее

Cramer's lightning round: Amicus Therapeutics is an ideal spec